MLYS - Company ID 0001933414
Mineralys Therapeutics, Inc. has filed 350 public company documents between 2022 and 2026. The most frequent type is insider trade (143 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| SC 13G | Passive ownership stake | 3y ago2023-02-24 | - | View filing |
| SC 13D | Activist ownership stake | 3y ago2023-02-24 | - | View filing |
| SC 13D | Activist ownership stake | 3y ago2023-02-24 | - | View filing |
| 4 | Insider trade | 3y ago2023-02-16 | 2023-02-14 | View filing |
| 4 | Insider trade | 3y ago2023-02-16 | 2023-02-14 | View filing |
| 4 | Insider trade | 3y ago2023-02-16 | 2023-02-14 | View filing |
| 4 | Insider trade | 3y ago2023-02-16 | 2023-02-14 | View filing |
| 4 | Insider trade | 3y ago2023-02-16 | 2023-02-14 | View filing |
| SEC STAFF LETTER | SEC STAFF LETTER | 3y ago2023-02-15 | - | View filing |
| 8-K | Major company event | 3y ago2023-02-14 | 2023-02-14 | View filing |
| 4 | Insider trade | 3y ago2023-02-13 | 2023-02-09 | View filing |
| 4 | Insider trade | 3y ago2023-02-13 | 2023-02-09 | View filing |
| 4 | Insider trade | 3y ago2023-02-13 | 2023-02-09 | View filing |
| 4 | Insider trade | 3y ago2023-02-13 | 2023-02-09 | View filing |
| 4 | Insider trade | 3y ago2023-02-13 | 2023-02-09 | View filing |
| 4 | Insider trade | 3y ago2023-02-13 | 2023-02-09 | View filing |
| 4 | Insider trade | 3y ago2023-02-13 | 2023-02-09 | View filing |
| 4 | Insider trade | 3y ago2023-02-13 | 2023-02-09 | View filing |
| 4 | Insider trade | 3y ago2023-02-13 | 2023-02-09 | View filing |
| 4 | Insider trade | 3y ago2023-02-13 | 2023-02-09 | View filing |
| S-8 | Employee stock plan | 3y ago2023-02-10 | - | View filing |
| 424B4 | 424B4 | 3y ago2023-02-10 | - | View filing |
| EFFECT | EFFECT | 3y ago2023-02-09 | - | View filing |
| 3 | New insider ownership | 3y ago2023-02-09 | 2023-02-09 | View filing |
| 3 | New insider ownership | 3y ago2023-02-09 | 2023-02-09 | View filing |
| 3 | New insider ownership | 3y ago2023-02-09 | 2023-02-09 | View filing |
| 3 | New insider ownership | 3y ago2023-02-09 | 2023-02-09 | View filing |
| 3 | New insider ownership | 3y ago2023-02-09 | 2023-02-09 | View filing |
| 3 | New insider ownership | 3y ago2023-02-09 | 2023-02-09 | View filing |
| 3 | New insider ownership | 3y ago2023-02-09 | 2023-02-09 | View filing |
| 3 | New insider ownership | 3y ago2023-02-09 | 2023-02-09 | View filing |
| 3 | New insider ownership | 3y ago2023-02-09 | 2023-02-09 | View filing |
| S-1MEF | S-1MEF | 3y ago2023-02-09 | - | View filing |
| CERT | Exchange certification | 3y ago2023-02-09 | - | View filing |
| 3 | New insider ownership | 3y ago2023-02-09 | 2023-02-09 | View filing |
| 3 | New insider ownership | 3y ago2023-02-09 | 2023-02-09 | View filing |
| CORRESP | Company correspondence | 3y ago2023-02-07 | - | View filing |
| CORRESP | Company correspondence | 3y ago2023-02-07 | - | View filing |
| 8-A12B | 8-A12B | 3y ago2023-02-06 | - | View filing |
| S-1/A | S-1/A | 3y ago2023-02-02 | - | View filing |
| S-1 | IPO registration | 3y ago2023-01-18 | - | View filing |
| DRSLTR | DRSLTR | 3y ago2022-12-29 | - | View filing |
| DRS/A | DRS/A | 3y ago2022-12-29 | - | View filing |
| UPLOAD | SEC correspondence | 3y ago2022-12-16 | - | View filing |
| DRS/A | DRS/A | 3y ago2022-12-07 | - | View filing |
| DRSLTR | DRSLTR | 3y ago2022-12-06 | - | View filing |
| SEC STAFF LETTER | SEC STAFF LETTER | 3y ago2022-12-01 | - | View filing |
| UPLOAD | SEC correspondence | 3y ago2022-12-01 | - | View filing |
| DRS | DRS | 3y ago2022-11-04 | - | View filing |
| D | D | 4y ago2022-06-13 | - | View filing |